Treatment of acute fibrinous organizing pneumonia following hematopoietic cell transplantation with etanercept

Bone Marrow Transplant. 2017 Jan;52(1):141-143. doi: 10.1038/bmt.2016.197. Epub 2016 Aug 15.

Authors

G L Simmons¹, H M Chung¹, J M McCarty¹, A A Toor¹, D Farkas², K Miller², W B Clark¹

Affiliations

¹ Department of Internal Medicine, Division of Hematology/Oncology and Palliative Care, Virginia Commonwealth University, Bone Marrow Transplant Program, Richmond, VA, USA.
² Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Virginia Commonwealth University, Richmond, VA, USA.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Etanercept / adverse effects*
Hematopoietic Stem Cell Transplantation / adverse effects*
Humans
Male
Middle Aged
Pneumonia / pathology
Pneumonia / therapy*
Transplantation Conditioning / adverse effects*
Transplantation Conditioning / methods

Substances

Etanercept